Sign in

CIK 0001651625

  • Accelerated filer

AC Immune SA

Sign in to watch
Ticker
ACIU
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
Switzerland
Entity type
Other
Phone
+41 213459121
Business address
EPFL INNOVATION PARK, BUILDING B, 1015 LAUSANNE, Switzerland, 00000
Open-market buys, last 90 days
$0
in 0 filings
Open-market sales, last 90 days
$0
in 0 filings

Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.

Date Insider Transaction Shares Price Value Owned after
2026-06-11 Twyman Roy Ervin Director Grant or award +16,568 92,556
2026-06-11 Twyman Roy Ervin Director Grant or award · Share Option (right to buy) +38,889 38,889
2026-06-11 AGUIAR-LUCANDER RENEE Director Grant or award +16,568 51,136
2026-06-11 AGUIAR-LUCANDER RENEE Director Grant or award · Share Option (right to buy) +38,889 38,889
2026-06-11 Zuegel Martin Interim CEO Grant or award +33,136 71,408
2026-06-11 Zuegel Martin Interim CEO Grant or award · Share Option (right to buy) +77,778 77,778
2026-06-11 Buetler Monika Director Grant or award +17,751 71,656
2026-06-11 Buetler Monika Director Grant or award · Share Option (right to buy) +41,667 41,667
2026-06-11 June Carl Howard Director Grant or award +16,568 67,556
2026-06-11 June Carl Howard Director Grant or award · Share Option (right to buy) +38,889 38,889
2026-05-15 Pfeifer Andrea Chief Executive Officer Sale 10b5-1 −10,000 $2.79 $28K 3,820,288
2026-04-15 Pfeifer Andrea Chief Executive Officer Sale 10b5-1 −10,000 $3.14 $31K 3,830,288
2026-04-15 Pfeifer Andrea Chief Executive Officer Purchase 10b5-1 −10,000 $3.14 $31K 3,830,288

Page 1 of 1 · 13 trades